首页> 美国卫生研究院文献>Gut and Liver >Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
【2h】

Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions

机译:肝性脑病的评估和管理:现状和未来方向

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatic encephalopathy is a spectrum of neurocognitive manifestations often seen in patients with liver injury or rarely in patients with portosystemic shunting without liver injury. It can be divided into minimal (covert) hepatic encephalopathy and overt hepatic encephalopathy, depending on the severity. Patients with hepatic encephalopathy have compromised clinical outcomes, decreased quality of life, and increased healthcare utilization, often resulting in a heavy financial and personal burden on caregivers. The diagnosis remains largely clinical, with the exclusion of possible other causes for the altered mental status. Current treatment strategies include nonabsorbable disaccharides and antibiotics. This review will focus on the diagnosis, management and clinical impact of hepatic encephalopathy.
机译:肝性脑病是一系列神经认知表现,常在肝损伤患者中见到,很少在没有肝损伤的门静脉系统分流患者中见到。根据严重程度,它可以分为轻度(隐性)肝性脑病和明显性肝性脑病。肝性脑病患者的临床结局受损,生活质量下降,医疗保健利用率提高,常常给护理人员带来沉重的财务和个人负担。该诊断在很大程度上仍然是临床的,排除了精神状态改变的其他可能原因。当前的治疗策略包括不可吸收的二糖和抗生素。这项审查将侧重于肝性脑病的诊断,管理和临床影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号